Literature DB >> 30617866

Expression of fluconazole resistance-associated genes in biofilm from 23 clinical isolates of Candida albicans.

Ce Shi1,2, Jinyan Liu2, Wenjing Li1, Yue Zhao1, Lingning Meng1, Mingjie Xiang3,4.   

Abstract

This study aimed to establish the influence of biofilm from clinical isolates of Candida albicans on fluconazole resistance, focusing on efflux pumps and azole-targeted enzymes. Twenty-three C. albicans clinical isolates were collected from two hospitals in Shanghai, China. Antifungal susceptibility tests were performed on biofilm and planktonic cells. A crystal violet assay was used to monitor biofilm growth. Real-time RT-PCR was performed to quantify the expression of the transporter-related genes MDR1, CDR1, and CDR2 as well as ERG11, a gene encoding an enzyme targeted by antifungal drugs. Fluconazole resistance was shown to increase in biofilm in a time-dependent manner. No significant differences were observed between different strains of C. albicans. Genes encoding efflux pumps were overexpressed in early stages of biofilm formation and could also be induced by fluconazole. While ERG11 was not upregulated in biofilm, it was overexpressed upon the addition of fluconazole to biofilm and planktonic cells. Gene expression also appeared to be related to the original genotype of the strain. The upregulation of genes encoding efflux pumps demonstrates their role in the development of fluconazole resistance during the early stages of C. albicans biofilm formation.

Entities:  

Keywords:  Biofilm; Candia albicans; Efflux pump; Fluconazole resistance

Mesh:

Substances:

Year:  2019        PMID: 30617866      PMCID: PMC6863221          DOI: 10.1007/s42770-018-0009-2

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  27 in total

Review 1.  Candida biofilms on implanted biomaterials: a clinically significant problem.

Authors:  Gordon Ramage; José Pedro Martínez; José Luis López-Ribot
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

2.  TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.

Authors:  Alix T Coste; Mahir Karababa; Françoise Ischer; Jacques Bille; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2004-12

3.  Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.

Authors:  T C White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Resistance of Candida albicans biofilms to antifungal agents in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

5.  Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

6.  Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.

Authors:  R Ben-Yaacov; S Knoller; G A Caldwell; J M Becker; Y Koltin
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Microbiol Methods       Date:  2007-11-21       Impact factor: 2.363

8.  Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms.

Authors:  K F Mitchell; H T Taff; M A Cuevas; E L Reinicke; H Sanchez; D R Andes
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

Review 9.  A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport.

Authors:  M D Marger; M H Saier
Journal:  Trends Biochem Sci       Date:  1993-01       Impact factor: 13.807

10.  Role for cell density in antifungal drug resistance in Candida albicans biofilms.

Authors:  Palani Perumal; Satish Mekala; W LaJean Chaffin
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

View more
  8 in total

1.  Inhibition of Phospholipase by Orlistat as an Alternate Therapy to Combat Opportunistic Mycosis Caused by C. albicans.

Authors:  Hardi Sinde; Priyanka Patel; Kunjan M Kikani; Dhyey R Kothari; Bhavtosh A Kikani
Journal:  Curr Microbiol       Date:  2021-04-03       Impact factor: 2.188

2.  Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.

Authors:  Chanika Maenchantrarath; Pradchama Khumdee; Seksun Samosornsuk; Narissara Mungkornkaew; Worada Samosornsuk
Journal:  BMC Microbiol       Date:  2022-06-10       Impact factor: 4.465

3.  Glass ionomer cement modified by a imidazolium salt: adding antifungal properties to a biomaterial.

Authors:  Alexandre Ehrhardt; Jéssica Zolim Andreatto Mandelli; Vanessa Bérgamo; William Lopes; Ricardo Keitel Donato; Régis A Zanette; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2021-05-05       Impact factor: 2.476

4.  In vitro Antibiotic and Modulatory Activity of Mesosphaerum suaveolens (L.) Kuntze against Candida strains.

Authors:  Adrielle Rodrigues Costa; José Weverton Almeida Bezerra; Rafael Pereira da Cruz; Maria Audilene de Freitas; Viviane Bezerra da Silva; João Cruz Neto; Antonia Thassya Lucas Dos Santos; Maria Flaviana Bezerra Morais Braga; Leomara Andrade da Silva; Maria Ivaneide Rocha; Jean Paul Kamdem; Marcello Iriti; Sara Vitalini; Antonia Eliene Duarte; Luiz Marivando Barros
Journal:  Antibiotics (Basel)       Date:  2020-01-27

5.  Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro.

Authors:  Wenli Feng; Jing Yang; Yan Ma; Zhiqin Xi; Ying Ji; Qiao Ren; Huan Ning; Shaoyan Wang
Journal:  Infect Drug Resist       Date:  2021-06-02       Impact factor: 4.003

6.  In vitro and in vivo anti-Candida activity of citral in combination with fluconazole.

Authors:  Katherine Miranda-Cadena; Cristina Marcos-Arias; Aitzol Perez-Rodriguez; Iván Cabello-Beitia; Estibaliz Mateo; Elena Sevillano; Lucila Madariaga; Guillermo Quindós; Elena Eraso
Journal:  J Oral Microbiol       Date:  2022-03-02       Impact factor: 5.474

7.  Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates.

Authors:  Amira M El-Ganiny; Hend A Kamel; Nehal E Yossef; Basem Mansour; Ahmed M El-Baz
Journal:  Saudi Pharm J       Date:  2022-01-19       Impact factor: 4.562

Review 8.  Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis.

Authors:  Hazrat Bilal; Muhammad Shafiq; Bing Hou; Rehmat Islam; Muhammad Nadeem Khan; Rahat Ullah Khan; Yuebin Zeng
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.